Pieris Pharmaceuticals Inc. is a biotechnology company that focuses on the discovery and development of novel protein therapeutics using its proprietary Anticalin® technology platform. The company aims to address unmet medical needs in the field of oncology and respiratory diseases. With a strong pipeline and strategic partnerships, Pieris Pharmaceuticals Inc. is poised for growth in the pharmaceutical industry.
